Netherlands· NL-84329cc1be6e

Everolimus CF 5 mg, tabletten

A everolimus product containing everolimus, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC L01EG02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about everolimusAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Everolimus is registered in 11 of 19 countries.

Countries holding a registration under ATC L01EG02 (everolimus), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search everolimus products by name

Everolimus · ATC L01EG02

11 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of everolimus costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $27.93 in United States to $142.94 in Switzerland — a ×5.1 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Everolimus · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$142.94
IT Italy$125.91
ES Spain$105.57
US United States$27.93 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EVEROLIMUS
Manufacturer: Centrafarm B.V.
Country: Netherlands (NL)
ATC code: L01EG02
ATC class: Everolimus
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
120361

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for everolimus.

Graded by severity as the source publishes them — 165 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check everolimus against other medicines How interaction checks work

Everolimus · interactions on record

428 records

165 severe
255 moderate
8 minor

Most severe, free to view

AprepitantA04AD12severe
NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Everolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All everolimus products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Certican, Everolimus Ethypharm
Belgium · Certican, Everolimus Eg
Bulgaria · Еверолимус Крка, Еверолимус Майлан
Cyprus · Certican, Everolimus Pharmazac
Czechia · Certican, Everolimus Accord
Germany · Certican, Everofin
Denmark · Certican, Everolimus Krka
Estonia · Certican, Everolimus Krka
Spain · Certican, Everolimus Accord
Finland · Aderolio, Certican
France · Certican, Everolimus Arrow
United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
Greece · Certican, Everolimus Faran
Croatia · Certican, Everolimus Krka
Hungary · Certican, Everolimus Accord
Ireland · Certican, Everolimus Tad
Iceland · Afinitor, Certican
Italy · Certican, Everolimus Accord
Liechtenstein · Afinitor, Votubia
Lithuania · Certican, Everolimus Norameda
Luxembourg · Certican, Everolimus Eg
Latvia · Certican, Everolimus Norameda
Malta · Certican, Everolimus Ascend
Norway · Afinitor, Certican
Poland · Aderolio, Certican
Portugal · Certican, Everolimus Ethypharm
Romania · Certican, Everolimus Accord
Sweden · Certican, Everolimus Avansor
Slovenia · Certican, Everolimus Krka
Slovakia · Certican, Everolimus Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f3b7f297-1db0-4fb9-ab9b-9f008d333708
GET /v1/drugs/f3b7f297-1db0-4fb9-ab9b-9f008d333708?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120361_smpc.pdf",
  "strength": null,
  "atc_label": "Everolimus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120361",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "EVEROLIMUS"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120361.pdf",
  "authorised_at": "2018/06/06",
  "procedure_number": "NL/H/3914/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120361",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about everolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console